Mental Health Symposium
Topic of talk: qEEG in mood disorders: From biomarkers and predictors of treatment response to a new era of psychedelic research.
Martin Brunovsky, M.D., Ph.D., is the Head of the Brain Electrophysiology research programme at the National Institute of Mental Health in Czech Republic, and Assistant Professor at the Department of Psychiatry and Medical Psychology at the Third Faculty of Medicine of the Charles University Prague. He received his M.D. grade at the P. J. Safarik University in Kosice (Slovakia) in 1999 and his Ph.D. at the Charles University in Prague (Czech Republic) in 2004. After finishing his residency, he became a neurologist and neurophysiologist at the Prague Psychiatric Center and Assistant Professor at the Charles University in Prague.His research involves the application of brain imaging techniques, particularly qEEG, moving it from the analysis of waveforms to a neuroimaging tool (i.e. LORETA) with a special interest in the evaluation of CNS drug effects in pharmaco-EEG, sleep, and event-related potentials studies, as well as in the qEEG prediction of response to psychopharmacological treatment. His research interests and clinical experience are mostly oriented to ethiopathogenesis, diagnosis and treatment of schizophrenia, Alzheimer’s disease, affective disorders, cognitive disorders and sleep disorders.
Dr. Brunovsky is the Vice President of the International Pharmaco EEG Society (www.ipeg-society.org), a member of the EEG & Clinical Neuroscience Society, and a member of the European Psychiatric Association.